Insider Trading Summary for Alkermes Plc. (ALKS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Feb-24 10:00 PM View:	08-Feb-24 Payment of Exercise ($2.46M)	Pops Richard F Director and CEO, Alkermes plc Director		Alkermes Plc. - ALKS	12% 1.05M to 1.18M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:06 PM View:	23-Feb-24 Payment of Exercise ($53.55K)	Landine Michael J SVP, Corp Dev., Alkermes, Inc.		Alkermes Plc. - ALKS	12% 250.44K to 281.73K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:39 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Wysenski Nancy Director		Alkermes Plc. - ALKS	17% 27.07K to 31.6K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:35 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Snyderman Nancy Lynn Md Director		Alkermes Plc. - ALKS	28% 16.26K to 20.78K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:27 PM View:	07-Jul-23 Payment of Exercise ($92.57K)	Cooke Shane Director		Alkermes Plc. - ALKS	3% 94.12K to 96.98K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:30 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Gaynor Richard Director		Alkermes Plc. - ALKS	29% 15.83K to 20.36K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:36 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Wilson Frank Anders Director		Alkermes Plc. - ALKS	29% 15.83K to 20.36K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:03 PM View:	23-Feb-24 Payment of Exercise ($100.95K)	Hopkinson Craig C. EVP R&D, Chief Medical Officer		Alkermes Plc. - ALKS	94% 56.56K to 109.71K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:02 PM View:	18-Mar-24 Private Sale (Planned) ($292.74K)	Nichols Christian Todd SVP, Chief Commercial Officer		Alkermes Plc. - ALKS	36% 48.48K to 65.91K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:07 PM View:	10-Feb-24 Payment of Exercise ($29.72K)	Daglio David Angelo Jr. Director		Alkermes Plc. - ALKS	8% 95.17K to 103.14K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:11 PM View:	10-Feb-24 Payment of Exercise ($29.72K)	McKeon Brian P Director		Alkermes Plc. - ALKS	32% 25.17K to 33.14K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:04 PM View:	23-Feb-24 Payment of Exercise ($114.73K)	Jackson Blair Curtis EVP, Chief Operating Officer		Alkermes Plc. - ALKS	38% 114.12K to 157.8K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:08 PM View:	23-Feb-24 Payment of Exercise ($76.50K)	Brown Iain Michael SVP, Chief Financial Officer		Alkermes Plc. - ALKS	40% 82.84K to 116.34K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:26 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Alva Emily Peterson Director		Alkermes Plc. - ALKS	60% 12.31K to 19.72K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:01 PM View:	15-Feb-24 Planned Private Option Sale ($85.68K)	Laurencin Cato T Director		Alkermes Plc. - ALKS	103% 7.48K to 15.17K	0	0	--	--	Show Txns Hide Txns

10-Jul-23 8:37 PM View:	07-Jul-23 Payment of Exercise ($42.73K)	Wright Christopher I Director		Alkermes Plc. - ALKS	100% 0 to 7.27K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:07 PM View:	23-Feb-24 Payment of Exercise ($100.95K)	Gaffin David Joseph EVP, CLO, Alkermes, Inc.		Alkermes Plc. - ALKS	30% 126.85K to 164.78K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:09 PM View:	27-Feb-24 Sale ($8.18K)	Parisi Samuel Joseph VP, Finance (Interim PAO)		Alkermes Plc. - ALKS	98% 3.9K to 7.72K	0	0	--	--	Show Txns Hide Txns

Alkermes Plc. (ALKS)

Last Year

29-Apr-23 -- 28-Apr-24

Company Sentiment

Drug Delivery

Drugs

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--